Hospital uses AI for the first time in the UK to treat cervical cancer patient

  • The Royal Surrey Trust treated Emma McCormick, 44, using the treatment Ethos 
  • This is the first time a UK hospital used AI to treat a patient with cervical cancer
  • Nine other cervical cancer patients are being treated in the same way

A hospital has used artificial intelligence to treat a patient with cervical cancer for the first time in the UK.

The treatment, called Ethos, involves a machine which uses the technology to deliver a prescription dose to tumours.

The Royal Surrey Trust treated Emma McCormick, 44, using adaptive radiotherapy after she was diagnosed with the cancer last April.

The Royal Surrey Trust treated Emma McCormick (pictured), 44, using adaptive radiotherapy after she was diagnosed with the cancer last April

The AI technology uses daily CT scans to target specific areas needing radiotherapy. This helps avoid damage to healthy tissue and limit side-effects.

Miss McCormick, from West Sussex, received five AI treatments a week for five weeks before having a further fortnight of internal radiation therapy. By the end of August, she was given the all-clear.

Following the success of Miss McCormick’s treatment, created by healthcare company Varian, nine other cervical cancer patients are being treated in the same way. 

A hospital has used artificial intelligence to treat a patient with cervical cancer for the first time in the UK (file photo used)

Patients are given slots of around 20 to 25 minutes per treatment, although Ms McCormick’s was slightly longer as she was the first patient.

She received five AI treatments a week for five weeks before having a further two weeks of brachytherapy.

By the end of August, she was given the all-clear.

Outlining her thoughts on being the first patient to receive the new treatment, she told the PA news agency: ‘I suppose there was a little bit of excitement because, although I was going through treatment, I was almost helping other people.

‘(I thought) If it works for me, and they get information from me, it can help somebody else. It definitely worked and did what it was meant to do and so hopefully that helps others.’

The AI technology uses daily CT scans to target specific areas needing radiotherapy. This helps avoid damage to healthy tissue and limit side-effects (file photo used)

Ms McCormick, who is from West Sussex, added: ‘The treatment that I had and the care the staff gave me, I can’t fault it at all. It was exceptional care.

‘Everyone was so nice, I felt I was really well looked after. If I had any questions or concerns about anything, we had a conversation. I had weekly phone calls too just to see how I was getting on.’

Dr Alex Stewart, who treated Ms McCormick, said one of the benefits of the treatment is that it allows for more precision, meaning there are fewer side-effects for the patients.

She added that, due to the cervix and uterus being mobile, previous treatments sessions involved working out where the cervix might have moved to, doing a scan to check, and then applying radiotherapy to that entire area.

She told PA: ‘When the patient comes in for treatment, they lay down and a scan is performed.

‘On that scan we work out exactly where the bladder is, where the bowel is, where the uterus and cervix are. Then we make a new radiotherapy plan each day for the patient.

‘Previously this would have taken hours and hours but, with the advent of artificial intelligence, the machine contours where it sees everything to be.

‘We then check that carefully and the machine makes a new radiotherapy plan each day.

‘We’re able to do it in around five minutes or so.’

The entire process to scan, contour and plan for Ms McCormick’s treatment took about 30 minutes and is roughly the same for other patients, she added.

Following the success with Ms McCormick’s treatment, nine other cervical cancer patients are being now treated in the same way.

Dr Stewart said: ‘I’m sure we’ll be developing it and rolling it out to all of our pelvic cancers eventually.

‘Whether we do other cancers is difficult to say. There’s a lot of benefit to using it so I think it will be used in a number of different areas. I think it’s really, really exciting.’

Louise Stead, chief executive at the trust, said: ‘I am very proud of how we are leading the way in this area of adaptive radiotherapy.

‘The trust is fortunate to have extremely strong physics and research departments that excel at what they do.

‘The dedication, commitment and hard work of all the staff in the department is also key to achieving this UK first. Congratulations and well done to all those involved.’

Source: Read Full Article